[144] Madrigal Pharmaceuticals, Inc. SEC Filing
Madrigal Pharmaceuticals, Inc. (MDGL) Rule 144 notice shows proposed and recent sales of common stock by an identified insider. The filing lists a proposed sale of 1,000 shares through Morgan Stanley Smith Barney with an aggregate market value of $390,224.20, slated for 08/20/2025 on NASDAQ. Those 1,000 shares were acquired the same day by exercise of options under a registered plan and paid in cash. The filer also reported prior sales by the same person in the past three months: 2,000 shares on 08/18/2025 for $764,481.20 and 4,100 shares on 08/15/2025 for $1,503,481.48. The notice includes the standard insider representation that no undisclosed material adverse information is known.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� l'avviso ai sensi della Rule 144 riporta vendite proposte e recenti di azioni ordinarie da parte di un soggetto interno identificato. Il documento indica una vendita proposta di 1.000 azioni tramite Morgan Stanley Smith Barney per un valore di mercato complessivo di $390.224,20, prevista per il 20/08/2025 sul NASDAQ. Quelle 1.000 azioni sono state acquisite lo stesso giorno mediante esercizio di opzioni nell'ambito di un piano registrato e pagate in contanti. Il dichiarante ha inoltre segnalato vendite precedenti effettuate dalla stessa persona negli ultimi tre mesi: 2.000 azioni il 18/08/2025 per $764.481,20 e 4.100 azioni il 15/08/2025 per $1.503.481,48. L'avviso contiene la dichiarazione standard dell'insider che non 猫 a conoscenza di informazioni negative rilevanti non divulgate.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� el aviso conforme a la Rule 144 muestra ventas propuestas y recientes de acciones comunes por parte de un insider identificado. La presentaci贸n indica una venta propuesta de 1.000 acciones a trav茅s de Morgan Stanley Smith Barney por un valor de mercado agregado de $390.224,20, prevista para el 20/08/2025 en NASDAQ. Esas 1.000 acciones fueron adquiridas el mismo d铆a mediante el ejercicio de opciones bajo un plan registrado y pagadas en efectivo. El declarante tambi茅n inform贸 ventas previas de la misma persona en los 煤ltimos tres meses: 2.000 acciones el 18/08/2025 por $764.481,20 y 4.100 acciones el 15/08/2025 por $1.503.481,48. El aviso incluye la representaci贸n habitual del insider de que no conoce informaci贸n inconveniente material no divulgada.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� Rule 144 韱奠電� 韸轨爼 雮措秬鞛愱皜 鞝滌晥頃橁卑雮� 斓滉芳鞐� 氤挫湢 欤检嫕鞚� 毵る弰頃� 雮挫毄鞚� 氤挫棳欷嶋媹雼�. 鞝滌稖靹滊鞐愲姅 Morgan Stanley Smith Barney毳� 韱淀暣 齑� 鞁滉皜臧� $390,224.20鞚� 1,000欤� 毵る弰臧赌 2025-08-20 NASDAQ鞐愳劀 鞓堨爼霅橃柎 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 1,000欤茧姅 臧欖潃 雮� 霌彪霅� 頂岆灉鞐� 霐半ジ 鞓奠厴 頄夓偓搿� 旆摑霅橃柎 順勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 鞝滌稖鞚胳潃 霕愴暅 臧欖潃 靷瀸鞚� 斓滉芳 3臧滌洈 雮挫棎 鞁れ嫓頃� 鞚挫爠 毵る弰 雮挫棴鞚� 氤搓碃頄堨姷雼堧嫟: 2025-08-18鞐� 2,000欤� 毵る弰鞎� $764,481.20, 2025-08-15鞐� 4,100欤� 毵る弰鞎� $1,503,481.48. 韱奠氍胳棎電� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵�鞝曥爜 鞝曤炒臧� 鞐嗢潓鞚� 頇曥澑頃橂姅 鞚茧皹鞝侅澑 雮措秬鞛� 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� l'avis au titre de la Rule 144 indique des ventes propos茅es et r茅centes d'actions ordinaires par un initi茅 identifi茅. Le d茅p么t mentionne une vente propos茅e de 1 000 actions via Morgan Stanley Smith Barney pour une valeur de march茅 totale de $390鈥�224,20, pr茅vue le 20/08/2025 sur le NASDAQ. Ces 1 000 actions ont 茅t茅 acquises le m锚me jour par exercice d'options dans le cadre d'un plan enregistr茅 et r茅gl茅es en esp猫ces. Le d茅clarant a 茅galement signal茅 des ventes ant茅rieures par la m锚me personne au cours des trois derniers mois聽: 2 000 actions le 18/08/2025 pour $764鈥�481,20 et 4 100 actions le 15/08/2025 pour $1鈥�503鈥�481,48. L'avis contient la d茅claration standard de l'initi茅 selon laquelle il n'a connaissance d'aucune information pr茅judiciable importante non divulgu茅e.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� Die Rule鈥�144-Mitteilung weist auf vorgeschlagene und k眉rzliche Verk盲ufe von Stammaktien durch einen identifizierten Insider hin. Die Einreichung nennt einen geplanten Verkauf von 1.000 Aktien 眉ber Morgan Stanley Smith Barney mit einem Gesamtmarktwert von $390.224,20, terminiert 蹿眉谤 den 20.08.2025 an der NASDAQ. Diese 1.000 Aktien wurden am selben Tag durch Aus眉bung von Optionen im Rahmen eines registrierten Plans erworben und bar bezahlt. Der Melder berichtete au脽erdem 眉ber fr眉here Verk盲ufe derselben Person in den letzten drei Monaten: 2.000 Aktien am 18.08.2025 蹿眉谤 $764.481,20 und 4.100 Aktien am 15.08.2025 蹿眉谤 $1.503.481,48. Die Mitteilung enth盲lt die 眉bliche Insider鈥慉ngabe, dass keine nicht offengelegten, wesentlichen negativen Informationen bekannt sind.
- Acquisition source disclosed: 1,000 shares were acquired by exercise of options under a registered plan, indicating a standard, compliant mechanism.
- Broker and transaction details provided: Broker name, approximate sale date, and aggregate market values are included, supporting transparency.
- Insider selling activity: Recent sales total 7,100 shares within the reporting window, which could increase available supply and pressure the stock price.
- No 10b5-1 plan date disclosed: The filing does not indicate whether sales were part of a pre-established trading plan, limiting clarity on whether sales were preplanned.
Insights
TL;DR: Insider executed option exercise and has been selling shares recently, indicating liquidity actions rather than disclosed adverse events.
The filing documents an executive or insider sale activity under Rule 144: a contemporaneous option exercise of 1,000 shares followed by an intended sale, and two recent sales totaling 6,100 shares generating about $2.27 million gross proceeds. The source of the 1,000-share lot is an exercise under a registered plan, which supports that these are planned, compliant transactions rather than opportunistic off-market disposals. For investors, the activity is noteworthy as insider supply may exert modest near-term selling pressure, but the filing contains no information about company fundamentals, material events, or deviations from standard compliance practices.
TL;DR: Documentation appears procedurally complete but reveals concentrated insider sales over a short period.
The notice provides required details: broker, amounts, acquisition dates, and representation regarding material nonpublic information. The pattern鈥攅xercise of options and immediate sales plus two earlier sales within five days鈥攕uggests liquidity monetization by the named individual. This is procedurally typical when insiders exercise options and sell to cover taxes or diversify. The filing does not disclose any trading plan adoption date or 10b5-1 details, so it is not possible to confirm whether sales were preplanned under an automated plan.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� l'avviso ai sensi della Rule 144 riporta vendite proposte e recenti di azioni ordinarie da parte di un soggetto interno identificato. Il documento indica una vendita proposta di 1.000 azioni tramite Morgan Stanley Smith Barney per un valore di mercato complessivo di $390.224,20, prevista per il 20/08/2025 sul NASDAQ. Quelle 1.000 azioni sono state acquisite lo stesso giorno mediante esercizio di opzioni nell'ambito di un piano registrato e pagate in contanti. Il dichiarante ha inoltre segnalato vendite precedenti effettuate dalla stessa persona negli ultimi tre mesi: 2.000 azioni il 18/08/2025 per $764.481,20 e 4.100 azioni il 15/08/2025 per $1.503.481,48. L'avviso contiene la dichiarazione standard dell'insider che non 猫 a conoscenza di informazioni negative rilevanti non divulgate.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� el aviso conforme a la Rule 144 muestra ventas propuestas y recientes de acciones comunes por parte de un insider identificado. La presentaci贸n indica una venta propuesta de 1.000 acciones a trav茅s de Morgan Stanley Smith Barney por un valor de mercado agregado de $390.224,20, prevista para el 20/08/2025 en NASDAQ. Esas 1.000 acciones fueron adquiridas el mismo d铆a mediante el ejercicio de opciones bajo un plan registrado y pagadas en efectivo. El declarante tambi茅n inform贸 ventas previas de la misma persona en los 煤ltimos tres meses: 2.000 acciones el 18/08/2025 por $764.481,20 y 4.100 acciones el 15/08/2025 por $1.503.481,48. El aviso incluye la representaci贸n habitual del insider de que no conoce informaci贸n inconveniente material no divulgada.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� Rule 144 韱奠電� 韸轨爼 雮措秬鞛愱皜 鞝滌晥頃橁卑雮� 斓滉芳鞐� 氤挫湢 欤检嫕鞚� 毵る弰頃� 雮挫毄鞚� 氤挫棳欷嶋媹雼�. 鞝滌稖靹滊鞐愲姅 Morgan Stanley Smith Barney毳� 韱淀暣 齑� 鞁滉皜臧� $390,224.20鞚� 1,000欤� 毵る弰臧赌 2025-08-20 NASDAQ鞐愳劀 鞓堨爼霅橃柎 鞛堧嫟瓿� 旮办灛霅橃柎 鞛堨姷雼堧嫟. 頃措嫻 1,000欤茧姅 臧欖潃 雮� 霌彪霅� 頂岆灉鞐� 霐半ジ 鞓奠厴 頄夓偓搿� 旆摑霅橃柎 順勱笀鞙茧 歆�旮夒悩鞐堨姷雼堧嫟. 鞝滌稖鞚胳潃 霕愴暅 臧欖潃 靷瀸鞚� 斓滉芳 3臧滌洈 雮挫棎 鞁れ嫓頃� 鞚挫爠 毵る弰 雮挫棴鞚� 氤搓碃頄堨姷雼堧嫟: 2025-08-18鞐� 2,000欤� 毵る弰鞎� $764,481.20, 2025-08-15鞐� 4,100欤� 毵る弰鞎� $1,503,481.48. 韱奠氍胳棎電� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵�鞝曥爜 鞝曤炒臧� 鞐嗢潓鞚� 頇曥澑頃橂姅 鞚茧皹鞝侅澑 雮措秬鞛� 歆勳垹霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� l'avis au titre de la Rule 144 indique des ventes propos茅es et r茅centes d'actions ordinaires par un initi茅 identifi茅. Le d茅p么t mentionne une vente propos茅e de 1 000 actions via Morgan Stanley Smith Barney pour une valeur de march茅 totale de $390鈥�224,20, pr茅vue le 20/08/2025 sur le NASDAQ. Ces 1 000 actions ont 茅t茅 acquises le m锚me jour par exercice d'options dans le cadre d'un plan enregistr茅 et r茅gl茅es en esp猫ces. Le d茅clarant a 茅galement signal茅 des ventes ant茅rieures par la m锚me personne au cours des trois derniers mois聽: 2 000 actions le 18/08/2025 pour $764鈥�481,20 et 4 100 actions le 15/08/2025 pour $1鈥�503鈥�481,48. L'avis contient la d茅claration standard de l'initi茅 selon laquelle il n'a connaissance d'aucune information pr茅judiciable importante non divulgu茅e.
Madrigal Pharmaceuticals, Inc. (MDGL) 鈥� Die Rule鈥�144-Mitteilung weist auf vorgeschlagene und k眉rzliche Verk盲ufe von Stammaktien durch einen identifizierten Insider hin. Die Einreichung nennt einen geplanten Verkauf von 1.000 Aktien 眉ber Morgan Stanley Smith Barney mit einem Gesamtmarktwert von $390.224,20, terminiert 蹿眉谤 den 20.08.2025 an der NASDAQ. Diese 1.000 Aktien wurden am selben Tag durch Aus眉bung von Optionen im Rahmen eines registrierten Plans erworben und bar bezahlt. Der Melder berichtete au脽erdem 眉ber fr眉here Verk盲ufe derselben Person in den letzten drei Monaten: 2.000 Aktien am 18.08.2025 蹿眉谤 $764.481,20 und 4.100 Aktien am 15.08.2025 蹿眉谤 $1.503.481,48. Die Mitteilung enth盲lt die 眉bliche Insider鈥慉ngabe, dass keine nicht offengelegten, wesentlichen negativen Informationen bekannt sind.
FAQ
What insider sales does the MDGL Form 144 disclose?
How much were the recent insider sales worth according to the filing?
How were the 1,000 shares acquired before the proposed sale?
Through which broker will the proposed sale be executed?
Does the filing state whether the seller knows of any undisclosed material information?
